[BCT] YoY Quarter Result on 30-Apr-2022 [#Q3]

Stock
[BCT] BriaCell Therapeutics Corp.
Announcement Date
29-Apr-2022
Financial Year
2022
Quarter
30-Apr-2022 [#Q3]
Profit Trend
QoQ- 4.68%
YoY- -3.88%
Quarter Report
BCT's Result
BCT's Financial Summary
View:
Show?
Quarter Result
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT 1,692 -4,895 2,302 2,395 298 284 -1,290 -
Tax -10,982 -528 -36 7,824 0 -11 176 -
NP 1,716 -4,367 2,302 2,395 298 284 -1,290 -
Tax Rate 648.99% - 1.56% -326.71% -0.02% 4.02% - -
Total Cost -1,716 4,367 -2,302 -2,395 -298 -284 1,290 -
Ratio Analysis
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/04/24 30/04/23 30/04/22 30/04/21 30/04/20 30/04/19 30/04/18 CAGR
EPS 0.11 -0.28 0.15 0.49 0.41 0.43 -2.45 -
EPS Diluted 0.11 -0.28 0.15 0.49 0.41 0.43 -2.45 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.